Beta Bionics, Inc.

Good afternoon and welcome to the Beta Bionics first quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentations, there will be a question and answer session and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded. I would now like to hand the conference over to Blake Bieber, Head of Investors Relations. Please go ahead.

Thank you.

Good afternoon, and thank you for joining Beta Bionics' first quarter 2025 earnings call. Joining me on the call today are Sean Saint, Beta Bionics' President and Chief Executive Officer, and Stephen Feider, Chief Financial Officer. Both the replay of this call and the press release discussing our first quarter 2025 results, the replay will be available for approximately one year following the conclusion of this call. Information recorded on this call speaks only as of today, May 6, 2025. Therefore, if you are listening to this replay, any time sensitive information may no longer be accurate. Also on our website is our supplemental first quarter 2025 earnings presentation and updated corporate presentations. We encourage you to reference those documents for a summary of key metrics and business updates. Before we begin, we would like to remind you that today's discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance, and operating plans. Please refer to the cautionary statements in the press release we issued earlier today, as well as our SEC filings, including our Form 10Q filed today, for detailed explanation of the limitations of such forward-looking statements. These documents contain and identify important factors that may cause actual results to differ materially from current expectations implied by our forward-looking statements. Please note that the forward-looking statements made during this call speak only as of today's date and we undertake no obligation to update them to reflect subsequent events or circumstances except to the extent required by law. Today's discussion will also include references to non-GAAP financial measures with respect to our performance, namely adjusted EBITDA. Non-GAAP financial measures are provided to give our investors information that we believe is indicative of our core operating performance and reflects our ongoing business operations. We believe these non-GAAP financial measures facilitate better comparisons of operating results across reporting periods. Any non-GAAP financial information presented should not be considered as a substitution independently or superior to results prepared in accordance with GAAP. Please refer to our earnings press release and supplemental earnings presentation on the investor relations section of our website for reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measure. With that, I'll now turn the call over to Sean.